Thyro3 Alpha Pharma

$13.00

Manufacturer: Alpha Pharma Substance: Liothyronine (T3) Pack: 25mcg (30 pills)

Thyro3 (Liothyronine) is a drug made on the basis of a hormone produced by the thyroid gland. Quite often, athletes use liothyronine to burn fat. Due to the additional intake of T3, its content in the blood increases, which significantly speeds up fat loss processes, and can also accelerate the growth hormone synthesis and increase the anabolic level.

Pharmacodynamics

Liothyronine replenishes the deficiency of thyroid hormones. Increases the need for tissues in oxygen, stimulates growth and differentiation of tissues, increases the level of basal metabolism (proteins, fats and carbohydrates). In small doses anabolic, and in large – catabolic effect. Inhibits the production of thyroid-stimulating hormone. Strengthens energy processes, positively affects the state of the nervous and cardiovascular systems, the liver and kidneys.

Pharmacokinetics

After oral administration, 95% is absorbed within 4 hours. The latent period is 4-8 hours. It binds to proteins in the blood. The maximum pharmacological effect occurs in 2-3 days. T1 / 2 – 2,5 days.

Side effects

  • Headache
  • Anxiety
  • Irritability
  • Sweating
  • Tachycardia
  • Arrhythmia
  • Angina pectoris
  • Heart failure
  • Dysmenorrhea
  • Allergic reactions

Contraindications

Hypersensitivity, thyrotoxicosis, diabetes mellitus, Addison’s disease, adrenal insufficiency, cachexia, IHD, pregnancy and lactation.

Measures of precaution and application features

With caution appoint elderly patients, with coronary artery disease (CHD), heart failure and certain forms of heart rhythm disturbances (tachyarrhythmias).

Even light, thyrotonin-induced hyperthyroidism should be avoided, especially if there is insufficient blood supply to the heart (coronary insufficiency), with heart failure or with tachyarrhythmias. When hypothyroidism of the thyroid gland caused by pituitary damage, it is necessary to find out whether there is a simultaneous insufficiency of the adrenal cortex. In this case, her treatment should begin before the appointment of thyroid hormone therapy.

Additional information

Manufacturer

Package

Substance